Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 59,291 | reported | 26 May 2026 | tx 26+151,250−67,594 |
| Praxis Precision Medicines, Inc. | 38,619 | reported | 12 Feb 2023 | tx 11+412,352−4,768 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 26 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,489 | 26.78 USD | |
| 22 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 22 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,861 | 26.78 USD | |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 16 Apr 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 17 Apr 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,862 | 20.22 USD | |
| 16 Apr 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 22 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 23 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 3,975 | 15.57 USD | |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 22 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 16 Jan 2026 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 22 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 24 Nov 2025 | SALE | KalVista Pharmaceuticals, Inc. | 3,813 | 13.45 USD | |
| 21 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 22 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 25 Aug 2025 | SALE | KalVista Pharmaceuticals, Inc. | 1,480 | 13.42 USD | |
| 22 Aug 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 22 Aug 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 21 Aug 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 22 Aug 2025 | SALE | KalVista Pharmaceuticals, Inc. | 1,864 | 13.22 USD |